Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Nathalie Labarriere"'
Autor:
Alexandra Fauvre, Margot Machu, Audrey Merienne, Nadia Vie, Thomas Bessede, Mathilde Robin, Veronique Garambois, Clara Taffoni, Nadine Laguette, Nadine Gervois‐Segain, Anne Jarry, Nathalie Labarriere, Yves Allory, Christel Larbouret, Laurent Gros, Diego Tosi, David B. Solit, Philippe Pourquier, Nadine Houédé, Celine Gongora
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 9, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/909d3363b27643e8a03718ec78c8c871
Autor:
Gwenann Cadiou, Tiffany Beauvais, Lucine Marotte, Sylvia Lambot, Cécile Deleine, Caroline Vignes, Malika Gantier, Melanie Hussong, Samuel Rulli, Anne Jarry, Sylvain Simon, Bernard Malissen, Nathalie Labarriere
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Immune checkpoint (IC) blockade and adoptive transfer of tumor-specific T-cells (ACT) are two major strategies to treat metastatic melanoma. Their combination can potentiate T-cell activation in the suppressive tumor microenvironment, but the autoimm
Externí odkaz:
https://doaj.org/article/340606cf6c7041f6bba4cce82a0f24d4
Autor:
Janin Chandra, Morten Hansen, Nathalie Labarriere, Ilaria Marigo, Fernando Souza-Fonseca-Guimaraes, Lazar Vujanovic, Yoshinobu Koguchi, Nicolas Jacquelot
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/887d1623bc2b4c4a954c89a2dce4ed11
Autor:
Sylvain Simon, Zhong Wu, J. Cruard, Virginie Vignard, Agnes Fortun, Amir Khammari, Brigitte Dreno, Francois Lang, Samuel J. Rulli, Nathalie Labarriere
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Among Immunotherapeutic approaches for cancer treatment, the adoptive transfer of antigen specific T cells is still a relevant approach, that could have higher efficacy when further combined with immune check-point blockade. A high number of adoptive
Externí odkaz:
https://doaj.org/article/3fcadf62073e44acb63c75d632689c8d
Autor:
Sylvain Simon, Nathalie Labarriere
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
Inhibitory properties of PD-1 receptor engagement on activated T cells are well established in physiologic and pathological contexts. In cancer, the use of checkpoint blockade, such as anti-PD-1 antibodies, becomes progressively a reference treatment
Externí odkaz:
https://doaj.org/article/6ea2614cb9d44681aeaeef8a493dd25f
Autor:
Mathilde Bobinet, Virginie Vignard, Laetitia Florenceau, Francois Lang, Nathalie Labarriere, Agnès Moreau-Aubry
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e75421 (2013)
The melanoma antigens MELOE-1 and MELOE-2 are encoded by a messenger, called meloe, overexpressed in melanomas compared with other tumour cell types and healthy tissues. They are both able to elicit melanoma-specific T cell responses in melanoma pati
Externí odkaz:
https://doaj.org/article/c77bf5b22fde4f0db0263c27d22b9484
Autor:
Delphine Carbonnelle, Virginie Vignard, Delphine Sehedic, Agnes Moreau-Aubry, Laetitia Florenceau, Maud Charpentier, Wolfgang Mikulits, Nathalie Labarriere, François Lang
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e75233 (2013)
Our previous studies on melanoma antigens identified two new polypeptides, named MELOE-1 and MELOE-2, that are involved in immunosurveillance. Intriguingly, these antigens are coded by distinct open reading frames (ORF) of the meloe mRNA which is sig
Externí odkaz:
https://doaj.org/article/1d1db63783204ef6b03048f3b617beab
Autor:
Mathilde Bobinet, Virginie Vignard, Anne Rogel, Amir Khammari, Brigitte Dreno, Francois Lang, Nathalie Labarriere
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51716 (2012)
MELOE-1 is an overexpressed melanoma antigen containing a HLA-A2 restricted epitope, involved in melanoma immunosurveillance of patients adoptively transferred with tumour infiltrating lymphocytes (TIL). The use of the full-length antigen (46 aa) for
Externí odkaz:
https://doaj.org/article/91a7af20a71b4098b1545b6eee5152b8
Autor:
Nathalie Labarriere, Brigitte Dreno, Francois Lang, Nadine Gervois, Amir Khammari, Anne-Chantal Knol, Tiphaine Parrot, Emilie Varey, Virginie Vignard, Sylvain Simon
Figure S1 illustrates the robustness and reproducibility of the methodolgy used to sort and amplify Melan-A specific T cells from HLA-A2 PBMC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1efaa7d719c65d004eaa5e80f5cb599
https://doi.org/10.1158/0008-5472.22416527.v1
https://doi.org/10.1158/0008-5472.22416527.v1
Autor:
Nathalie Labarriere, Brigitte Dreno, Francois Lang, Nadine Gervois, Amir Khammari, Anne-Chantal Knol, Tiphaine Parrot, Emilie Varey, Virginie Vignard, Sylvain Simon
Legends of supplemental figures S1, S2, S3 and S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b2c3ca029bf6cebf47320e7e8c51ed
https://doi.org/10.1158/0008-5472.22416515.v1
https://doi.org/10.1158/0008-5472.22416515.v1